MRVI

Maravai LifeSciences Holdings, Inc. MRVI

MRVI
Maravai LifeSciences Holdings, Inc. IMVT
Immunovant, Inc. FOLD
Amicus Therapeutics, Inc. DNLI
Denali Therapeutics Inc. HALO
Halozyme Therapeutics, Inc. ROIV
Roivant Sciences Ltd. SHC
Sotera Health Company CERT
Certara, Inc. SEER
Seer, Inc. CCCC
C4 Therapeutics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode MRVI IMVT FOLD DNLI HALO ROIV SHC CERT SEER CCCC
6M 74.32 % 16.01 % 28.09 % 21.02 % 6.44 % 62.68 % 46.05 % -8.13 % 10.50 % 81.45 %
YTD -41.89 % -32.39 % -10.85 % -26.25 % 33.51 % 32.78 % 12.70 % 11.26 % -5.15 % -38.52 %
1Y -61.38 % -42.15 % -20.35 % -42.71 % 18.81 % 35.47 % -0.39 % 5.52 % 11.06 % -61.73 %
3Y -83.14 % 82.14 % -24.20 % -54.69 % 48.31 % 248.70 % 124.74 % 0.85 % -66.57 % -72.79 %
5Y -89.31 % -60.48 % -49.39 % -65.25 % 126.74 % 54.23 % -38.84 % -68.86 % -96.09 % -90.35 %
10Y -89.31 % 71.16 % 21.17 % -28.34 % 395.75 % 54.23 % -38.84 % -68.86 % -96.09 % -91.17 %
From the beginning -89.31 % 71.16 % -42.48 % -28.34 % 1 408.24 % 54.23 % -38.84 % -68.86 % -96.09 % -91.17 %

Dividend